Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00496106 · ClinicalTrials.gov registry record · NA

Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes

A NA study of Ovarian Cancer, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
204
Enrollment target
1
Study location

NCT00496106: Completed NA study of Ovarian Cancer, sponsored by University of California, Irvine.

NCT00496106 is a NA study of Ovarian Cancer that has completed, run by University of California, Irvine. The registered enrollment target is 204 participants, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00496106, a NA study of Ovarian Cancer, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
204 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to: 1. Test the efficacy of psychosocial telephone counseling (PTC) for cervical cancer survivors, compared to usual care. 2. Evaluate the longitudinal immune and neuroendocrine parameters in cervical cancer patients who have received PTC, compared to usual care. 3. Examine the longitudinal relationship between PTC associated modulations of quality of life (QOL) measures and biologic parameters (immune and neuroendocrine).

Conditions Studied

Interventions

  • BEHAVIORAL Telephone counseling
  • BEHAVIORAL Telephone interview

Study Locations (1)

California

  • University of California, Irvine Medical Center - Orange

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2007-08
Est. Completion 2011-02
Phase NA
University of California, Irvine

368 total trials

What the finished NCT00496106 record still lists

NCT00496106 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (72% lower).

The record links to 1 condition, with Ovarian Cancer appearing as the primary indexed condition, and to 2 interventions - of which Telephone counseling is the first listed.

NCT00496106 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00496106 about?

NCT00496106 is a clinical study titled "Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes". The purpose of the study is to: 1. Test the efficacy of psychosocial telephone counseling (PTC) for cervical cancer survivors, compared to usual care. 2. Evaluate the longitudinal immune and neuroendocrine parameters in cervical cancer patients who have received PTC, compared to usual care. 3. Exam...

What is the current status of trial NCT00496106?

This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2007-08. Estimated completion is 2011-02.

What conditions does trial NCT00496106 study?

This clinical trial studies the following conditions: Ovarian Cancer.

What interventions are being tested in trial NCT00496106?

The interventions under investigation include: Telephone counseling (BEHAVIORAL), Telephone interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT00496106?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00496106 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ovarian Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00496106's enrollment target sits among peer trials

204 97th of 322 higher than 226 of 322 other Ovarian Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Ovarian Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

  • NCT04249830 · 204 participants · NA

    Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults

  • NCT04503395 · 204 participants · NA

    ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

  • NCT04793776 · 204 participants · NA

    Manage Emotions to Reduce Aggression (MERA)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00496106, the US trial registry maintained by the National Library of Medicine. NCT00496106 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.